Oxaliplatin trials for Pancreatic Ductal Adenocarcinoma

All Oxaliplatin trials · All Pancreatic Ductal Adenocarcinoma trials

Phase breakdown

Recruiting trials studying Oxaliplatin for Pancreatic Ductal Adenocarcinoma

• A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer
  NCT07024615 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
  NCT06131840 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 48 locations
• MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
  NCT06586515 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 104 locations

Common questions

How many trials study Oxaliplatin for Pancreatic Ductal Adenocarcinoma?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.